Irreversible Cardiotoxicity after Adjuvant Treatment with Trastuzumab in a Case of Breast Cancer

Ewer M.S. , Vooletich M.T. , Durand J.B. , Woods M.L. , Davis J.R. , Valero V. , Lenihan D.J. : Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment. J Clin Oncol, 23: 7820–7826, 2005.

Jensen B.V. : Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer. Semin Oncol, 33: S15–21, 2006.

McArthur H.L. , Chia S. : Cardiotoxicity of trastuzumab in clinical practice. N Engl J Med, 357: 94–95, 2007.

Speyer J. : Cardiac dysfunction in the trastuzumab clinical experience. J Clin Oncol, 20: 1156–1157, 2002.

Ewer M.S. , Gibbs H.R. , Swafford J. , Benjamin R.S. : Cardiotoxicity in patients receiving trastuzumab (Herceptin): Primary toxicity, synergistic or sequential stress, or surveillance artefact? Semin Oncol, 26: 96–101, 1999.

Hunt S.A. , Abraham W.T. , Chin M.H. , Feldman A.M. , Francis G.S. , Ganiats T.G. , Jessup M. , Konstam M.A. , Mancini D.M. , Michl K. , Oates J.A. , Rahko P.S. , Silver M.A. , Stevenson L.W. , Yancy C.W. , Antman E.M. , Smith S.C. Jr. , Adams C.D. , Anderson J.L. , Faxon D.P. , Fuster V. , Halperin J.L. , Hiratzka L.F. , Jacobs A.K. , Nishimura R. , Ornato J.P. , Page R.L. , Riegel B. ; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society: ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 112(12): e154–235, 2005.

Cardinale D. , Sandri M.T. , Colombo A. , Colombo N. , Boeri M. , Lamantia G. , Civelli M. , Peccatori F. , Martinelli G. , Fiorentini C. , Cipolla C.M. : Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation, 109: 2749–2754, 2004.

Chia S. , Clemons M. , Martin L.A. , Rodgers A. , Gelmon K. , Pond G.R. , Panasci L. : Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: A multicenter phase II trial. J Clin Oncol, 24: 2773–2778, 2006.